Abatacept for the treatment of adults with psoriatic arthritis: patient selection and perspectives.

Psoriasis (Auckl) · 2018 · PMC6047621 · PMID 30035098

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

19 This result did not reach statistical significance; consequently, statistical testing was not performed on the remaining secondary endpoints. 19 Most other secondary endpoints trended higher for those receiving abatacept including improvements in the quality of life assessed by the short form (SF-36) physical component summary and in radiographic p

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.